Hyundai Pharmaceutical Co Ltd
KRX:004310
Hyundai Pharmaceutical Co Ltd
KRX:004310
Price:
9 460
KRW
2.83%
Market Closed
Market Cap:
₩247.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hyundai Pharmaceutical Co Ltd
KRX:004310
|
KR |
|
B
|
Bantas Bandirma Ambalaj Sanayi ve Ticaret AS
IST:BNTAS.E
|
TR |
|
Lem Holding SA
SIX:LEHN
|
CH |
|
Newrange Gold Corp
XTSX:NRG
|
CA |
|
ARN Media Ltd
ASX:A1N
|
AU |
|
J
|
JTL Industries Ltd
BSE:534600
|
IN |
Relative Value
The Relative Value of one
Hyundai Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
KRW.
Compared to the current market price of 9 460 KRW,
Hyundai Pharmaceutical Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Hyundai Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Hyundai Pharmaceutical Co Ltd Competitors
Hyundai Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
Hyundai Pharmaceutical Co Ltd
KRX:004310
|
247.2B KRW | 1.3 | 238.4 | 47 | 139.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.5 | 12.7 | 16.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
